NINDS migraine information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/migraine/migraine.htm. Accessed Feb. 29, 2016.
Headache: Hope through research. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/headache/detail_headache.htm. Accessed Feb. 29, 2016.
Cutrer FM, et al. Pathophysiology, clinical manifestations and diagnosis of migraine in adults. http://www.uptodate.com/home. Accessed Feb. 29, 2016.
Daroff RB, et al. Headache and other craniofacial pain. In: Bradley's Neurology in Clinical Practice. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. https://www.clinicalkey.com. Accessed Feb. 29, 2016.
Bajwa ZH, et al. Acute treatment of migraine in adults. http://www.uptodate.com/home. Accessed Feb. 26, 2016.
Bajwa ZH, et al. Preventive treatment of migraine in adults. http://www.uptodate.com/home. Accessed Feb. 29, 2016.
Neurological diagnostic tests and procedures. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/misc/diagnostic_tests.htm. Accessed Feb. 29, 2016.
Headaches and complementary health approaches. National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/health/pain/headachefacts.htm?nav=gsa. Accessed Feb. 29, 2016.
Ramzan M, et al. Headache, migraine and stroke. http://www.uptodate.com/home. Accessed Feb. 29, 2016.
Cruse RP. Management of migraine headache in children. http://www.uptodate.com/home. Accessed Feb. 29, 2016.
Ask Mayo Expert. Migraine. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
Tintinalli JE, et al. Atypical and serotonergic antidepressants. In: Tintinalli's Emergency Medicine: A Comprehensive Study Guide. 7th ed. New York, N.Y.: The McGraw-Hill Companies; 2011. http://www.accessmedicine.com. Accessed April 26, 2013.
Swanson JW (expert opinion). Mayo Clinic, Rochester, Minn. March 3, 2016.
Cognitive-Behavioral Therapy (CBT). American Chronic Pain Association. https://theacpa.org/treatment/cognitive-behavioral-therapy-cbt. Accessed March 3, 2016.
FDA allows marketing of first medical device to prevent migraine headaches. U.S. Food and Drug Administration, http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm388765.htm. Accessed March 9, 2016.
Aimovig (approval letter). Biologic License Application 761077. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077. Accessed May 30, 2018.